INmune Bio Inc

NASDAQ:INMB  
9.37
+0.25 (+2.74%)
Earnings Announcements

Inmune Bio, Inc. Announces Second Quarter 2022 Results And Provides Business Update

Published: 08/03/2022 21:41 GMT
INmune Bio Inc (INMB) - Inmune Bio, Inc. Announces Second Quarter 2022 Results and Provides Business Update.
Inmune Bio Inc - Qtrly Net Loss per Common Share - Basic and Diluted $0.38.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.